CoChat

Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme

Open access
Landier, Jordi, Parker, Daniel M, Thu, Aung Myint, Lwin, Khin Maung, Delmas, Gilles, Nosten, François H, Andolina, Chiara, Aguas, Ricardo, Ang, Saw Moe, Aung, Ei Phyo, Baw, Naw Baw, Be, Saw Aye, B'Let, Saw, Bluh, Hay, Bonnington, Craig A., Chaumeau, Victor, Chirakiratinant, Miasa, Cho, Win Cho, Christensen, Peter, Corbel, Vincent, Day, Nicholas PJ, Dah, Saw Hsa, Delmas, Gilles, Dhorda, Mehul, Dondorp, Arjen M, Gaudart, Jean, Gornsawun, Gornpan, Haohankhunnatham, Warat, Hla, Saw Kyaw, Hsel, Saw Nay, Htoo, Gay Nay, Htoo, Saw Nay, Imwong, Mallika, John, Saw, Kajeechiwa, Ladda, Kereecharoen, Lily, Kittiphanakun, Praphan, Kittitawee, Keerati, Konghahong, Kamonchanok, Khin, Saw Diamond, Kyaw, Saw Win, Landier, Jordi, Ling, Clare, Lwin, Khin Maung, Lwin, Khine Shwe War, Ma, Naw K' Yin, Marie, Alexandra, Maung, Cynthia, Marta, Ed, Minh, Myo Chit, Miotto, Olivo, Moo, Paw Khu, Moo, Ku Ler, Moo, Merry, Na, Naw Na, Nay, Mar, Nosten, François H., Nosten, Suphak, Nyo, Slight Naw, Oh, Eh Kalu Shwe, Oo, Phu Thit, Oo, Tun Pyit, Parker, Daniel M., Paw, Eh Shee, Phumiya, Choochai, Phyo, Aung Pyae, Pilaseng, Kasiha, Proux, Stéphane, Rakthinthong, Santisuk, Ritwongsakul, Wannee, Salathibuphha, Kloloi, Santirad, Armon, Sawasdichai, Sunisa, von Seidlein, Lorenz, Shee, Paw Wah, Shee, Paw Bway, Tangseefa, Decha, Thu, Aung Myint, Thwin, May Myo, Tun, Saw Win, Wanachaloemlep, Chode, White, Lisa J, White, Nicholas J, Wiladphaingern, Jacher, Win, Saw Nyunt, Yee, Nan Lin, Yuwapan, Daraporn · 2018 · The Lancet
Cited by 184

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Potentially untreatable Plasmodium falciparum malaria threatens the Greater Mekong subregion. A previous series of pilot projects in Myanmar, Laos, Cambodia, and Vietnam suggested that mass drug administration was safe, and when added to provision of early diagnosis and treatment, could reduce the reservoir of P falciparum and interrupts transmission. We examined the effects of a scaled-up programme of this strategy in four townships of eastern Myanmar on the incidence of P falciparum malaria. METHODS: The programme was implemented in the four townships of Myawaddy, Kawkareik, Hlaingbwe, and Hpapun in Kayin state, Myanmar. Increased access to early diagnosis and treatment of malaria was provided to all villages through community-based malaria posts equipped with rapid diagnostic tests, and treatment with artemether-lumefantrine plus single low-dose primaquine. Villages were identified as malarial hotspots (operationally defined as >40% malaria, of which 20% was P falciparum) with surveys using ultrasensitive quantitative PCR either randomly or targeted at villages where the incidence of clinical cases of P falciparum malaria remained high (ie, >100 cases per 1000 individuals per year) despite a functioning malaria post. During each survey, a 2 mL sample of venous blood was obtained from randomly selected adults. Hotspots received targeted mass drug administration with dihydroartemisinin-piperaquine plus single-dose primaquine once per month for 3 consecutive months in addition to the malaria posts. The main outcome was the change in village incidence of clinical P falciparum malaria, quantified using a multivariate, generalised, additive multilevel model. Malaria prevalence was measured in the hotspots 12 months after mass drug administration. FINDINGS: Between May 1, 2014, and April 30, 2017, 1222 malarial posts were opened, providing early diagnosis and treatment to an estimated 365 000 individuals. Incidence of P falciparum malaria decreased by 60 to 98% in the four townships. 272 prevalence surveys were undertaken and 69 hotspot villages were identified. By April 2017, 50 hotspots were treated with mass drug administration. Hotspot villages had a three times higher incidence of P falciparum at malarial posts than neighbouring villages (adjusted incidence rate ratio [IRR] 2·7, 95% CI 1·8-4·4). Early diagnosis and treatment was associated with a significant decrease in P falciparum incidence in hotspots (IRR 0·82, 95% CI 0·76-0·88 per quarter) and in other villages (0·75, 0·73-0·78 per quarter). Mass drug administration was associated with a five-times decrease in P falciparum incidence within hotspot villages (IRR 0·19, 95% CI 0·13-0·26). By April, 2017, 965 villages (79%) of 1222 corresponding to 104 village tracts were free from P falciparum malaria for at least 6 months. The prevalence of wild-type genotype for K13 molecular markers of artemisinin resistance was stable over the three years (39%; 249/631). INTERPRETATION: Providing early diagnosis and effective treatment substantially decreased village-level incidence of artemisinin-resistant P falciparum malaria in hard-to-reach, politically sensitive regions of eastern Myanmar. Targeted mass drug administration significantly reduced malaria incidence in hotspots. If these activities could proceed in all contiguous endemic areas in addition to standard control programmes already implemented, there is a possibility of subnational elimination of P falciparum. FUNDING: The Bill & Melinda Gates Foundation, the Regional Artemisinin Initiative (Global Fund against AIDS, Tuberculosis and Malaria), and the Wellcome Trust.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(18)30792-x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 184

Metadata

Authors
Landier, J., Parker, D. M., Thu, A. M., Lwin, K. M., Delmas, G., Nosten, F. H., Andolina, C., Aguas, R., Ang, S. M., Aung, E. P., Baw, N. B., Be, S. A., B'Let, S., Bluh, H., Bonnington, C. A., Chaumeau, V., Chirakiratinant, M., Cho, W. C., Christensen, P., Corbel, V., Day, N. P., Dah, S. H., Delmas, G., Dhorda, M., Dondorp, A. M., Gaudart, J., Gornsawun, G., Haohankhunnatham, W., Hla, S. K., Hsel, S. N., Htoo, G. N., Htoo, S. N., Imwong, M., John, S., Kajeechiwa, L., Kereecharoen, L., Kittiphanakun, P., Kittitawee, K., Konghahong, K., Khin, S. D., Kyaw, S. W., Landier, J., Ling, C., Lwin, K. M., Lwin, K. S. W., Ma, N. K. Y., Marie, A., Maung, C., Marta, E., Minh, M. C., Miotto, O., Moo, P. K., Moo, K. L., Moo, M., Na, N. N., Nay, M., Nosten, F. H., Nosten, S., Nyo, S. N., Oh, E. K. S., Oo, P. T., Oo, T. P., Parker, D. M., Paw, E. S., Phumiya, C., Phyo, A. P., Pilaseng, K., Proux, S., Rakthinthong, S., Ritwongsakul, W., Salathibuphha, K., Santirad, A., Sawasdichai, S., von Seidlein, L., Shee, P. W., Shee, P. B., Tangseefa, D., Thu, A. M., Thwin, M. M., Tun, S. W., Wanachaloemlep, C., White, L. J., White, N. J., Wiladphaingern, J., Win, S. N., Yee, N. L., & Yuwapan, D.
Venue
The Lancet
Publisher
Elsevier BV
Published
2018-05
Volume
391
Issue
10133
Pages
1916-1926
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2802085197
Cited by
184
References
5
FWCI
24.89
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. https://app.cochat.ai/papers/10.1016/s0140-6736(18)30792-x
The paper
Landier, J., Parker, D. M., Thu, A. M., Lwin, K. M., Delmas, G., Nosten, F. H., Andolina, C., Aguas, R., Ang, S. M., Aung, E. P., Baw, N. B., Be, S. A., B'Let, S., Bluh, H., Bonnington, C. A., Chaumeau, V., Chirakiratinant, M., Cho, W. C., Christensen, P., . . . Yuwapan, D. (2018). Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. The Lancet. https://doi.org/10.1016/s0140-6736(18)30792-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.